Implementation Guide CH VACD
6.0.0-ballot - ballot
This page is part of the CH VACD (R4) (v6.0.0-ballot: STU 6 Ballot) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Generated Narrative: Immunization TCF01-IMMUN2
Profile: CH VACD Immunization
Author of the content: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
CH VACD Extension Immunization Medication Reference: Medication HAVRIX 1440 Inj Susp
CH VACD Extension verificationStatus: SNOMED CT 76104008: Not confirmed
Entry Resource Cross References
- entry: Identifier:
urn:oid:2.999.1.2.3.4/855bdd69-0a39-4241-b208-9b248a62fb76- container: Identifier: Uniform Resource Identifier (URI)/urn:uuid:e2233a2f-d1c2-459d-b4fe-4920c35339e7
- relationcode: replaces
identifier: urn:oid:2.999.1.2.3.4/e2233a2f-d1c2-459d-b4fe-4920c35339e7
status: Completed
vaccineCode: Havrix 1440
patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
occurrence: 2021-05-27
recorded: 2021-05-27 00:00:00+0200
lotNumber: AHAVB946A
route: Intramuscular use
| Actor |
| PractitionerRole |
note: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-02)
| TargetDisease | DoseNumber[x] |
| Viral hepatitis, type A (disorder) | 1 |